Lead Authorship of CARRA Registry Manuscripts
Not currently accepting applications.
CARRA is seeking investigators to serve as lead authors of manuscripts using CARRA Registry data. Two manuscripts are currently planned: one to characterize children with psoriatic arthritis and enthesitis related arthritis and one to characterize etanercept use in the treatment of JIA. The manuscript projects will be joint collaborations between CARRA and the pharmaceutical company sponsor. This is an excellent opportunity to acquire practical experience with analyzing Registry data and receive project-based mentoring. Statistical support will be provided. We anticipate additional similar opportunities in the future.
Applicants must have completed a pediatric rheumatology fellowship, be employed as a pediatric rheumatologist in the United States or Canada, and be CARRA Members. Early Investigators are encouraged to apply. Formal training in epidemiology and prior authorship of published studies are desirable but not required. Applicants must have sufficient time to dedicate to the project, estimated to be not less than approximately 50 hours distributed over several months.
The CARRA Registry PIs and Scientific Director will review all applications and select the lead authors.
While two applicants will be chosen for the specific manuscripts listed above, CARRA will maintain a list of interested persons for additional opportunities that develop. The list will be renewed yearly. The chosen applicants will work directly with a senior CARRA Registry Intern and the CARRA Registry Scientific Director to produce a manuscript for submission to a scientific journal. There is no direct financial support provided for this opportunity. Statistician/data analyst effort and manuscript publication costs will be covered by CARRA.
Requirements and Responsibilities:
The selected applicants will work with the project team to:
- Devise and write the statistical analysis plan
- Interpret the study results and create necessary tables and figures
- Draft and revise the manuscript to its final form
- Submit the manuscript for publication
- Revise and resubmit the manuscript as necessary until it is accepted for publication
The selected applicants will participate in regularly occurring conference calls with the study team.
Applications must consist of the following materials:
- Research Statement: Describe what you hope to gain from this experience and how it would fit into your long-term career goals, including your disease area interests. This must include a statement that you will be able to devote the time necessary to complete the manuscript within the proposed timeline. 200 word maximum.
- NIH Biosketch (maximum limit of 5 pages)
- Letter of Recommendation: Signed letter of recommendation from a CARRA member supporting your application.
Contact Kelly Mieszkalski ([email protected]) or (919) 668-7531 with questions.